Join us on December 14 for our Patient-Focused Sessions on Multiple Myeloma, taking place in Charlotte, NC! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Cure Connections

Before Dr. Eskander turns to the future treatment of ovarian cancer, participants consider how the treatment journey can affect caregivers.
A breakdown of the support networks patients can build and rely on as they receive treatment for ovarian cancer.
Considerations for maintaining mental and emotional well-being while going through a diagnosis of and treatment for ovarian cancer.
Doña Harman shares how stigma surrounding cancer affected the reactions of some around her, while others offered their support.
More

Cure Expert Connections

The importance of support networks and a multidisciplinary team when managing advanced-stage renal cancer.
A discussion regarding the significance of dose modification to mitigate toxicity burden.
Steven Gallant, a stage 4 renal cell cancer survivor, discusses how he managed the toxicities of cabozantinib frontline therapy.
A discussion regarding the frontline treatment options for aggressive renal cell cancer, and the factors considered in choosing the appropriate therapy.
More

Cure TV

Dr. Georgina Long
The overall survival rate in patients with melanoma has increased exponentially in the past decade. But thanks to the use of combinations in the treatment of melanoma, the future looks even brighter, according to one expert from the Melanoma Institute Australia.
Dr. Sham Mailankody
As patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.
Sarah Christ
When others assume that patients with lung cancer must have smoked to get the disease, this stigma can affect patient outcomes.
 
Nagashree Seetharamu, MD, MBBS
Immunotherapy in combination with chemotherapy is becoming a popular treatment for patients with lung cancer, but patients need to understand the side effects.
More

Cure Speaking Out

More
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×